Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency

The receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mediates the viral–host interaction and is a target for most neutralizing antibodies. Nevertheless, SARS-CoV-2 RBD mutations pose a threat due to their role in host cell entry via the human angiotensin-...

Full description

Bibliographic Details
Published in:Biomolecules
Main Authors: Ahmed L. Alaofi, Mudassar Shahid
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/9/1273